Dr. Clyde Yancy of Northwestern University on a promising experimental heart drug.
An experimental heart drug developed by the Swiss pharmaceutical company Novartis shows promising results. The new drug, currently referred to as “L C Z 696” may change the course of treatment and prolong the lives of patients suffering from heart failure. For some insight, Dr. Clyde Yancy from Northwestern University joins Hari Sreenivasan via Skype from Windham, New Hampshire.
AIR DATE 8/31/14
PBS NewsHour provides in-depth analysis of current events with a news summary, live studio interviews and discussions of domestic and international issues. Amna Nawaz and Geoff Bennett co-anchor.
Watch Your Shows Many Ways
|
Click over to tpt.org/shows to watch your favorite TPT productions and PBS shows, anytime and anywhere.
Not only will this site work on your laptop or desktop computer, you'll also feel right at home on any modern smartphone or tablet. Stream away...
© 2025 Twin Cities Public Television